ABOUT
Smart discussion of the latest science and news on toxins in your food, water, and air, and what government agencies should be doing to protect public health. Written by EWG staff.
DONATE TO EWG!
Help us protect your health and environment! Please donate $5 to EWG today.
GET EWG'S TIPS & ACTION ALERTS
Sign Up here to receive email updates and tips from EWG and stay informed on the issues that matter most to you.
ENVIROBLOG VIA EMAIL
Join EWG's live chat with Chef Ann Cooper
School lunch: More fruits & veggies, please!
Texas Schools are Drilling for Dollars
Why do blowouts take so long to fix?
SEARCH ENVIROBLOG
FEATURED
Support the 2010 Safe Cosmetics Act. It's Urgent.
Why, oh why is there plastic in my aluminum water bottle?
Cell phone radiation series - Part 2: 8 Ways to reduce your exposure
Test Your Knowledge of Cosmetics Safety: 8 Myths Debunked
EWG's Tips for Parents: The Series
EWG's Tips to avoid BPA exposure
EWG on TV
Cutting the Pork from U.S. Farm Bill
Sunscreen safety & DC drinking water
Perchlorate in people, kids' personal care products & plastics, and sunscreen
BPA in baby formula & safe cosmetics
What can I do about fluoride in my water?
What is new carpet treated with? What can I do?
Are stainless steel water bottles safe?
Is mineral-based makeup safer?
PEOPLE TALKING TOXICS
TALK TO US
Did we miss something? Email Enviroblog.
« In the news: September 5, 2006 | Main | In the news: September 6, 2006 »
Drug-review fees help industry shape FDA agenda
According to the Wall Street Journal, the Food and Drug Administration is bargaining with the pharmaceutical industry for an increase in fees used for reviewing new drug applications-- a move experts say will give the industry a greater role in shaping the priorities of its regulator. "There is no doubt that user fees give the industry leverage on setting the agency's priorities, because of the negotiating process," says Dr. Kessler, former head of the FDA, and now dean of the medical school at the University of California, San Francisco. "There are significant risks, especially when a growing percentage of the budget comes from user fees." For the next five-year agreement, which will begin Oct. 1, 2007, fees could cover 66 percent or more of the drug-review budget.
We should have a local drug treatment center that tests a local effect of certaing drugs released on the market... We could have a better control this way and we could avoid people getting hurt from drugs that aren't viable in certain areas.